Regulation2 min read

Federal Study Reveals Public Wants Full Cannabis Legalization Over Rescheduling

Government-funded research shows Americans demand comprehensive marijuana reform beyond Trump's limited rescheduling proposal, signaling political pressure ahead.

April 29, 2026 at 3:03 PMCannabismarketcap

A federally funded study reveals Americans overwhelmingly support comprehensive cannabis legalization rather than the limited rescheduling approach favored by the incoming Trump administration. The research indicates public sentiment has shifted decisively toward full federal reform, creating potential political pressure that could influence legislative priorities and industry investment flows.

The findings arrive as cannabis operators face regulatory uncertainty following Trump's victory and his team's signals about pursuing Schedule III rescheduling rather than broader legalization. Major multi-state operators like Curaleaf (CURLF), Green Thumb Industries (GTBIF), and Trulieve (TCNNF) have seen volatile trading as investors weigh the implications of federal policy changes on interstate commerce and banking access.

While rescheduling would provide some tax relief through 280E elimination, it falls short of the comprehensive reform that would unlock full banking services, interstate commerce, and institutional investment. The study's results suggest politicians may face electoral consequences for supporting half-measures, potentially accelerating timelines for the SAFER Banking Act or broader legalization bills that have stalled in Congress.

The disconnect between public opinion and proposed policy creates strategic challenges for cannabis companies planning capital allocation and expansion. Operators must balance immediate opportunities from potential rescheduling benefits against longer-term positioning for full federal legalization that polling data suggests remains the public preference.

This data reinforces the industry's fundamental growth thesis while highlighting near-term policy risks. Cannabis stocks have traded on federal reform speculation for years, and evidence of strong public support provides ammunition for advocates pushing beyond incremental changes. The question becomes whether political leadership will respond to constituent pressure or maintain conservative approaches that leave the industry in regulatory limbo.